New Trial Data Confirm Clinical Effectiveness With NeuroStar TMS Therapy

Neuronetics sponsored an observational study of patients in the “real world” which confirms the clinical effectiveness and adherence rates of patients with Major Depressive Disorder (MDD) treated with the NeuroStar TMS Therapy system. This data continues to support the premise that patients with MDD who do not find relief with medication or who are unable to tolerate the medicines side effects have an effective, proven non-invasive and non-systemic  alternative.

“These data add to the impressive body of evidence that support the positive impact that TMS Therapy may have on patients living with major depression,” said Karl Lanocha, M.D., Medical Director of The TMS Center of New England, regarding the Neuronetics study.

The results of this study was released at the American Psychiatric Association meeting on May 15, 2011 in Hawaii.

The TMS Center of Colorado, LLC has been providing TMS therapy in Denver, Colorado since 2009. We serve the entire Rocky Mountain region including the front range communities; Colorado Springs, Boulder, Loveland, Fort Collins,  Longmont, Greeley, Denver as well as mountain communities such as Aspen, Vail and Steamboat Springs. We have also had patients from Wyoming, Montana and Missouri.

In addition to treating MDD, we are interested in the use of TMS for such off-label conditions as chronic pain, tinnitus, auditory hallucinations and Parkisons disease.

Tags: , , , , , , , ,

TMS Center of Colorado Makes KCNC News in Denver

Major Depressive Disorder (MDD) affects up to 50 million people in the USA. The affects of the disease on the person with MDD, their family and co-workers/employers can be devastating.  Time away from family and activities, lost work days and productivity, and side affects of  conventional treatment are some of the costs associated with MDD.  There is a relatively new treatment for MDD which was described in a television news segment which aired on March 22, 2011 on KCNC, Channel 4 in Denver.

This treatment is Transcranial Magnetic Stimulation TMS or rTMS).  NeuroStar TMS therapy is a FDA cleared treatment for major depressive disorder. TMS has also been used clinically in off label treatment and in clinical research to treat a wide variety of other neuorlogical and neuro-psychiatric conditions, including: chronic pain, post traumatic stress disorder (PTSD), phantom limb pain, depression associated with Parkinson’s Disease, post partum depression, tinnitus, auditory halucinations, and other conditions.

The NeuroStar TMS therapy system has been available in Colorado since November 2009 through the TMS Center of Colorado, LLC, located in Denver. This center was the first in Colorado (and the Rocky Mountain Region) to treat patients using this state of the art technology. There is hope for those suffering from MDD and other conditions.

Watch KCNC Coverage

Tags: , , , , , , , , , , , , ,

Reuters Health: Transcranial magnetic stimulation helpful in psychiatric disorders

There is a lot of research regarding the use of repetitive transcranial magnetic stimulation (rTMS) for a variety of psychiatric and neurological disorders. Some of the proposed treatments are premature others have a significant evidence basis for the use of rTMS. Dutch researchers recently reviewed current literature surrounding the use of rTMS in several psychiatric disorders. Their findings were published in Journal Clinical Psychiatry March 9, 2010 online paper. This was reported by Reuters Health in April 2010.

Pooled data from multiple studies indicate that repetitive transcranial magnetic stimulation (rTMS) is useful for depression, auditory verbal hallucinations, and possibly for negative symptoms of schizophrenia as well, according to Dutch researchers.

There is a video segment as well on The Doctors Channel.  rTMS is a non-invasive, non-systemic outpatient therapy. Now evidence-based, cutting edge therapy with few downside risks for the treatment of a variety of psychiatric and neurologic disorders.

Tags: , , , , , ,